October 2, 2012 | Derek Lowe looks at Andrew Lo's new funding model for biotech. Lo proposes raising $30 billion for oncology drug discovery as an investment--to finance discovery through securitization. Lowe says it's a fascinating idea, but points out that a very similar model was behind the recent financial crisis. In the Pipeline